7 reports

  • Uveitis, Global, All Pipeline Products, Phase I, 2017
  • Uveitis Therapeutics Market, Global, Licensing Deals with Disclosed Deal Value, 2006-2017

Indian Journal of Ophthalmology; ##(##): ## Pfizer.

  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • Clearside Biomedical, Inc.
  • Coherus BioSciences, Inc.

In Oct 2008, Japanese brewer Kirin merged its pharmaceutical unit with Kyowa Hakko Kogyo to create Kyowa Hakko Kirin.

  • Filgrastim
  • Pharmaceutical
  • Amgen Inc.
  • Coherus BioSciences, Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • COHERUS BIOSCIENCES INC, PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2012 TO YTD 2018
  • COHERUS BIOSCIENCES INC, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2012 TO YTD 2018

Summary Coherus BioSciences Inc (Coherus BioSciences) formerly known as BioGenerics Inc is a biosimilar platform company that develops and commercializes biosimilar drugs.The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar...

  • Biosimilar
  • Healthcare
  • Pharmaceutical
  • United States
  • Coherus BioSciences, Inc.
  • Mycenax Biotech and Pfizer have the highest number of molecules in pipeline
  • ACTIVE COMPANIES: CATEGORY AND PARAMETERS

You can easily book an appointment with one online.

  • Pharmaceutical
  • Therapy
  • Coherus BioSciences, Inc.
  • Mycenax
  • Pfizer Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017 (CONTD..1), H2 2017
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES

## ## ## F R/ W ## ## ## ## ## ## P III ## ## ## ## ## ## P II ## ## ## ## ## ## P I ## ## ## ## ## ## PC ## ## ## ## ## ## Un ## ## ## ## ## ## Total ## ## ## ## ## ## ## ## ## ## ## ## ## ## NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIE

  • Biosimilar
  • Pharmaceutical
  • United States
  • Product Initiative
  • Coherus BioSciences, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2016
  • Febrile Neutropenia - Products under Development by Companies

The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ##, ## and ## respectively.

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Coherus BioSciences, Inc.
  • Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Therapeutics under Development by Companies
  • Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Products under Development by Companies

## Phase I ## Preclinical ## Discovery ## Unknown ## Source: Global Markets Direct Stage of Development Number of Products Under Development Total ## Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Therapeutics under Development by Companies NUMBER OF PRODUCTS UNDER DEVELO

  • Biosimilar
  • Musculoskeletal Disorder
  • Pharmaceutical
  • United States
  • Coherus BioSciences, Inc.